Abstract We present an interdisciplinary overview of material engineering and emerging applications of iron oxide nanoparticles. We discuss material engineering of nanoparticles in the broadest sense, emphasizing size and shape control, large-area self-assembly, composite/hybrid structures, and surface engineering. This is followed by a discussion of several nontraditional, emerging applications of iron oxide nanoparticles, including nanoparticle lithography, magnetic particle imaging, magnetic guided drug delivery, and positive contrast agents for magnetic resonance imaging. We conclude with a succinct discussion of the pharmacokinetics pathways of iron oxide nanoparticles in the human body-an important and required practical consideration for any in vivo biomedical application, followed by a brief outlook of the field.
Introduction
Magnetic nanoparticles have been explored for numerous applications, such as catalysts for water splitting [1] [2] [3] , nanomedicine [4] [5] [6] [7] [8] [9] , and as matrices for matrix-assisted laser desorption/ionization (MALD) analysis [10] . Fundamental magnetic properties of nanoparticles critically define their potential applications, such as hard magnets for data storage and soft magnetic materials for magnetic switches. The properties of magnetic ferrite nanoparticles can be tuned by size [11] , surface [12] , shape [13] [14] [15] [16] , assembly [17, 18] , coupling [19] , and doping [20] [21] [22] . For instance, iron oxide nanoparticles over *28 nm 1 are ferrimagnetic and widely used for magnetic separation and as ferrofluids for liquid seals around the spinning drive shafts in hard disks and in loudspeakers to remove heat from the voice coil [23] . Iron oxide nanoparticles below 28 nm are superparamagnetic at room temperature (measurement time *100 s), and are heavily explored for biomedical applications, such as drug delivery [24, 25] , cancer therapy via magnetic hyperthermia [26] , as contrast agents for magnetic resonance imaging (MRI) [27] , and the emerging technique of magnetic particle imaging (MPI) [5] . Iron oxide nanoparticles smaller than 4 nm become primarily paramagnetic and can be used as positive (T 1 ) MRI contrast agents [28] . Recently, it has been shown that nonspherical iron oxide nanoparticles could improve their usefulness for biomedical applications. For examples, ultrathin iron oxide nanowires can serve as effective T 1 MRI contrast agents [29] . Iron oxide nanoworm-like particles formed by aggregation of spherical nanoparticles showed increased blood circulation time and more effective targeting [30] . Iron oxide nanocubes demonstrate extremely high r 2 relaxivity as negative MRI contrast agents [31] , and a high value of the specific absorption rate necessary for hyperthermia cancer treatment [32] . Iron oxide nanoparticle tracers are central to realizing the true potential of MPI in translational clinical applications [33] . Furthermore, the magnetic properties and performance of nanoparticles can be enhanced through interactions with their environments (e.g., self-assembly) and integration with other types of materials (composites or hybrid structures).
In practice, the behavior of nanoparticles is not only affected by their intrinsic properties but also by the surrounding environments [34, 35] . Besides that, nanoparticles can serve as fundamental building blocks, often through the process of self-assembly, to build artificial materials, which could be potentially used in a variety of applications [36] [37] [38] [39] [40] . As a result, it is possible to manipulate the spatial arrangement of nanoparticles so that their response to external stimuli can be tuned for different applications. Self-assembly is a technique that is both economical and powerful, and can be used to control the spatial arrangement of nanoparticles [41] [42] [43] [44] [45] [46] . Nanoparticle self-assembly can be affected by factors such as interparticle interactions, pre-patterned features, evaporation rate and directions of carrier fluids, and surfactants [47] [48] [49] [50] [51] . By controlling these factors, magnetic nanoparticles can be self-assembled into different patterns and morphologies [42, [52] [53] [54] . Instead of discussing the broad topic of selfassembly, we mainly concentrate on magnetic nanoparticle monolayers [55] and hierarchical nanoparticle assembly arrays [56] . To obtain long-range order in nanoparticle assembly, the nanoparticles should be made monodisperse, which can be realized by controlling the nucleation and growth of nanoparticles [57] [58] [59] . Recent interest in nanomaterial fabrication has gone beyond the production of a single material. Integration of multiple nanocomponents provides the capability of performing multiple tasks on a single platform [60] [61] [62] . For example, the integration of magnetic nanoparticles with fluorescent probes offer dual imaging probes [63] [64] , and magnetic nanoparticlequantum dot hybrid systems allow simultaneous multimodal imaging (microscopy, fluorescence, MRI) [65, 66] and therapy (hyperthermia) [67, 68] .
Among various possibilities, iron oxide nanoparticles offer significant promise due to their chemical stability, easy preparation, and low cost. In particular, their intrinsic biocompatibility makes iron oxide nanoparticles the primarily candidate for nanomedicine. For any biomedical and biological applications, water solubility and surface functionality of nanoparticles are key parameters to their interactions with biological systems. Surface coatings, in particular, directly affect nanoparticle cellular uptake [69] , biodistribution [70] , blood circulation [71] , and metabolism [72] . Therefore, surface engineering is essential to achieve various functionalities (e.g., biocompatibility and targeting). The enhanced physical and chemical properties of magnetic nanoparticles have enabled them to be used a wide range of new applications.
In this revimutipleew article, we will discuss material engineering aspects of iron oxide nanoparticles (e.g., size, shape, self-assembly, and hybrids) for improved chemical and physical properties, and surface engineering strategies for effective conjugation of functional molecules onto iron oxide nanoparticle surfaces. Furthermore, emerging applications of magnetic nanoparticles will be discussed, including magnet-guided drug delivery, positive MRI contrast agents, tracers for MPI, and nanoparticle lithography. Finally, the pharmacokinetic pathways of iron oxide nanoparticles, critical for in vivo applications, are also presented.
Material engineering Fundamentals of magnetic nanoparticles
Magnetic materials show a wide range of behaviors; at one end are the noninteracting spins in paramagnets and characterized by a temperature-dependent susceptibility (v = M/H µ 1/T) given by Curie's law. At the other end are the ferromagnets, with exchange interactions between spins, exhibiting hysteretic, M(H), behavior, and a finite coercivity, H C (M = 0), that is strongly dependent on the microstructure. Further, to minimize the overall magnetic energy, the material often forms domains, separated by domain walls with widths determined by the ratio of the exchange to anisotropy energies. However, if we reduce the size of any ferromagnet, we will ultimately reach a size where thermal energy (k B T * 25 meV, at 300 K) will compete with the prevailing anisotropy and randomize the magnetization direction such that for a typical measurement time (*100 s) the magnetization, M = 0, when no field is applied (H = 0). In other words, such materials show no coercivity (H C = 0), behaves similar to paramagnets but with very large moments, and are called superparamagnets. In practice, the randomization of the magnetization direction takes place by excitations over an energy barrier, e B = KV, given by the product of the anisotropy constant, K, and the volume, V. As a first approximation, neglecting the applied field, the Arrhenius law can describe thermal excitations of the magnetic moment over an energy barrier, e B , with relaxation time, s = s 0 exp (KV k B -1 T -1 ). Thus, superparamagnetic particles are defined by a characteristic diameter, D sp , or a characteristic temperature called the blocking temperature, T B , such that, for a given measurement time, a sharp division from superparamagnetic to ferromagnetic behavior can be observed either as a function of size (Fig. 1a) or temperature. Similar to a paramagnet, the magnetization response, M(H), of a superparamagnet is also given by the Langevin function. Note that because the relaxation time, s, depends exponentially on the energy barrier, KV, to reproducibly control the magnetic behavior of superparamagnetic nanoparticles, especially under alternating fields, such as in MPI [73] , tailored size and monodisperse size distributions in nanoparticle synthesis are required. Finally, for slightly larger particles, it is also important to consider the critical size that determines whether it is favorable to be uniformly magnetized (single domain), or to break into multiple domains to minimize their overall energy. Using simple models for domain stability in fine particles [74] and bulk properties available in the literature, one can determine the characteristic size, D sd , up to which single domains are stable [75] . For particles with cubic anisotropy, the critical radius, R c = 9/l 0 M s 2 , with D sd = 2 R c , at which the nanoparticle breaks into multidomains is a balance between the additional energy cost of introducing the domain wall and the reduction/gain in magnetostatic energy. This series of magnetic ''phases'' as a function of size is shown (Fig. 1b) for different ferromagnets and includes a ''single domain'' size (D sd ) below which the material will not support a multidomain particle [76] and a size (D sp ) defined by the superparamagnetic effect. Note that the characteristic size, D sp , is determined by the measurement time (typically, 100 s is assumed); however, if the nanoparticles are subject to AC measurements, where the sampling time is inverse of the frequency, the observed D sp would be smaller than that shown in Fig. 1b and inversely related to the sampling frequency.
Material engineering
Numerous metallic [77] [78] [79] [80] [81] and alloy [82] [83] [84] [85] magnetic nanoparticles have been synthesized, but here, we focus on the material engineering of iron oxide nanoparticles because of their ubiquity in nature, biocompatibility, and unique suitability for in vivo biomedical applications. Several synthetic methods are available for iron oxide nanoparticles, such as coprecipitation [86] , and hot injection [87] ; however, currently iron oxide nanoparticles of high-quality monodisperse type, controlled size, phasepurity, and high crystallinity without defects are normally produced in organic solvents at high temperatures [87] [88] [89] [90] [91] . In this section, the discussion of size and shape control will be primarily focused on the thermal decomposition of iron oleate in an organic solvent at high temperature: the socalled heat-up method [90, 92] . This method allows for the production of iron oxide nanoparticles with great reproducibility and control of physical parameters. The overall synthetic process includes two major steps: (1) preparation of the precursor, iron oleate (Fe(oleate) 3 ) complex, and (2) synthesis of nanoparticles at high temperatures. Originally, the synthesis of spherical iron oxide nanoparticles (5-25 nm) by the thermal decomposition of iron oleate in 1-octadecene at 300°C was reported with oleic acid (OA) as the only ligand [90] . Several modifications have been made to this process to achieve easy surface functionalization of spherical nanoparticles [64, 92, 93] , or preparation of iron oxide nanoparticles with other shapes, such as ultrathin nanowhiskers [16] , nanoplates and nanoflowers [15] , nanocubes [22] , and single crystalline nanoworms [14] . The modified ''heat-up'' methods for the production of various iron oxide nanoparticles will be elaborated in the following sections. One specific set of modifications is centered on temperature control and addition of ligands to alter the nucleation and growth process (Fig. 2 ).
Size and shape control of iron oxide nanoparticles
The size of spherical nanoparticles has been an important parameter to tune their magnetic properties for various applications. The size control of iron oxide nanoparticles has been primarily focused on two regimes for biomedical applications: paramagnetic ultrasmall nanospheres (\4 nm), and superparamagnetic nanoparticles (5-27 nm). The ultrasmall spheres were primarily developed as positive contrast agents for MRI [94] , while the superparamagnetic nanoparticles have been explored for various biomedical imaging, diagnostic, and therapy applications.
Because of the burst nucleation and rapid nanoparticle growth at high temperatures, the original ''heat-up'' process generally produces spherical iron oxide nanoparticles over 5 nm [90] . To produce ultrasmall (\4 nm) iron oxide nanoparticles, several modifications were made to the original process. First, the reaction was performed in diphenyl ether at lower reaction temperature (258°C), which is more viscous than the original solvent, 1-octadecene. Second, oleyl alcohol, a strong nanoparticle growth inhibitor, was introduced into the reaction. Both the lower temperature and the growth inhibitor slowed down the nanoparticle growth. Most importantly, the reaction was rapidly quenched shortly after nucleation stage, and nanoparticles were precipitated out of solution with cold hexane and ethanol to stop the nanoparticle growth. Figure 3 shows the transmission electron microscopy (TEM) image from a typical reaction similar to the previously reported procedure [94] . The high-resolution TEM image indicates the crystalline structures of these small nanoparticles.
The original ''heat-up'' method can effectively produce superparamagnetic iron oxide nanoparticles over 5 nm. However, the use of only OA, a strong binding ligand, causes serious problems for subsequent surface modification. Water solubility is key to any biomedical application. To address this problem, an effective and facile method was developed by simply introducing a co-ligand, trioctylphosphine oxide-TOPO-during synthesis [92] . The use of TOPO is critically important for the subsequent ligand exchange and surface functionalization. TOPO has a weaker binding to iron oxide nanoparticle surfaces, compared to OA [95] . Besides the weaker binding, the bulky C 8 tails of the TOPO molecule prevent them from forming a dense packing layer on the nanoparticle surfaces [78] . These two properties, together, provide the preferred sites for hydrophilic ligands to attach or bind, initiating the ligand exchange process. Most importantly, the introduction of TOPO during synthesis does not affect the overall size of the iron oxide nanoparticles, and it also leads toward the production of less-faceted nanoparticles. Figure 4 shows the TEM images of *12-nm iron oxide nanoparticles with OA only (a) and OA/TOPO (b) capping ligands under similar reaction conditions. The nanoparticles from OA-only ligand were faceted, while the nanoparticles with TOPO addition are not faceted. The more spherical nanoparticles were likely because the weaker adsorption of TOPO on nanoparticle surfaces allowed for effective rearrangement of surface atoms. Fourier transform-infrared spectroscopy (FTIR) spectrum (Fig. 4c ) of nanoparticles with TOPO/OA coatings exhibits the characteristic broad band of -P=O groups around 996 cm -1 [96] , indicating the presence of TOPO capping molecules on the nanoparticle surfaces. The broad bands at 1518 and 1401 cm -1 were from the carboxylic groups of the OA molecules on the nanoparticle surfaces.
Larger magnetic nanoparticles were prepared by the thermal decomposition of iron (III) oleate with excess OA in 1-octadecene at 318°C [96] . Such thermal decomposition approaches can produce monodispersed nanoparticles over a range of sizes, but the reactions are kinetically driven and sensitive to fluctuations that yield batch-tobatch variation in size and quality. In addition, if not carefully controlled, the reaction chemistry can produce variations in iron oxide phases and phase purities. Thus, nanoparticles were oxidized in situ with subsequent annealing at 318°C for up to 30 h to ensure that phasepure magnetite nanoparticles are synthesized. Furthermore, published protocols typically provide examples performed at small-scale and procedures that may not be scalable and frequently omit magnetic characterization that is critical for establishing suitability for applications such as MPI. With subsequent annealing, cores with median diameter in the range of 24-27 nm and geometric standard deviation of 1.06 were reproducibly synthesized in gram-scale quantities (Fig. 5a) . Diffraction confirmed the particles were phase-pure magnetite (Fe 3 O 4 ) with typical saturation magnetization of 350 kA/m measured by vibrating sample magnetometry (Fig. 5b) . Note that there is significant effort involved in preparing anhydrous iron-oleate precursors suitable for reproducible particle synthesis. Alternatively, the use of iron oxy-hydroxide, also produces very highquality nanoparticles, 25-30 nm in diameter, (Fig. 5c) , with iron oleate being formed as an intermediate during the reaction [97] . Control of iron oxide phase and phase purity, by appropriate oxidation during synthesis, is critical to achieving phase purity and suitable magnetic properties.
Until recently, the synthesis of iron oxide nanoparticles with nonspherical shapes using the ''heat-up'' method has been limited to a few reports on nanocubes with addition of sodium oleate, or other chemicals [98] [99] [100] [101] [102] . The recent fundamental understanding of the chemical microenvironments of iron oleate precursor has opened the doors to the synthesis of other shaped iron oxide nanoparticles [16] . In brief, thermogravimetric analysis (TGA) and density functional theory (DFT) electronic structure calculations suggest that the three ligands of iron oleate complex have different binding affinities to the Fe(III) center with one oleate having much higher binding energy (39.2 eV) than the other two (7.0 and 10.5 eV), which yield several temperature-control windows for synthesis consideration (Fig. 6) [16] . Based on the optimized electronic structures of the iron oleate complex (Fig. 6a) , two of the ligands are symmetric, and the third ligand is asymmetric. The TGA plot exhibited three distinct weight-loss windows: 150-250, 250-300, and 300-400°C. The weight-loss window of 150-250°C (Fig. 6b, region a) corresponds to the dissociation of the two symmetric ligands with lower binding energies. The weight losses are mainly due to the oleate ligand decomposition, releasing CO 2 gas. The weight loss ratio of about 2:1 agrees very well with two ligands of lower binding energies from the DFT calculations. The weight-loss window of 250-300°C reflects the decomposition of the third ligand (Fig. 6b, region b) , where the iron oxide nucleation initiates around 250°C, which has also been suggested by Hyeon [103] . The continuous weight loss at above 300°C was due to desorption of the decomposed ligands (Fig. 6b, region c) . The TGA studies suggested that the original ''heat-up'' method (directly heating of the reaction mixture over 300°C) overlooked the difference in the ligand microenvironments. Additional control within each temperature window offers great means for shape control, which serves as the foundation for the following experimental design to produce multiple-shaped iron oxide nanoparticles. The different binding abilities of the three ligands within Fe(III) oleate allowed to selectively decompose the lower binding ligands at 150°C. Interestingly, when a typical ''heat-up'' reaction was performed at 150°C, iron oxide nanowhiskers with dimensions of approximately 2 9 20 nm were obtained (Fig. 7a) . These nanostructures were single crystalline indicated by clear lattice fringes from the high-resolution TEM image of a single nanowhisker (Fig. 7a, inset) . The calculated fringe spacing of 0.298 nm was close to the lattice spacing of the (220) plane of the cubic iron oxide spinel structure [104] . The selected area electron diffraction pattern suggested maghemite (cFe 2 O 3 ) crystal phase (Fig. 7b) . The maghemite phase was further supported by Raman spectroscopy and X-ray photoelectron spectroscopy (XPS), as shown in Fig. 7c, d . The absence of the major feature peak of Fe 3 O 4 at around 670 cm -1 suggests that these nanowhiskers are not magnetite phase; [105] [103] . The low reaction temperature of the nanowhiskers minimized the generation of reducing gases, subsequently limiting the reduction of Fe 3? ions. Because of the extremely high surface-to-volume ratio, the iron oxide nanowhiskers showed a strong paramagnetic signal from the magnetization versus applied field (M-H) curve (Fig. 7e) . The observed magnetic property is a result of the high surface-to-volume ratio and surface ironligand complexation. The high percentage of surface atoms was linked to oleate ligands through coordination bonds, [16] behaving as iron complexes. The surface effects generate a magnetic ''dead layer'' on the nanoparticle surfaces, which is commonly observed in small magnetic nanoparticle systems [108] [109] [110] [111] [112] . Theoretical simulations also suggested that the dead layer is around 1 nm thick [113] , and this effect could be significant in high surface-to-volume ratio nanostructures, as observed in our nanowhisker system. It was hypothesized that the nanowhisker formation was directed by the undecomposed third ligand, which selfassembled into a soft template and facilitated the nanowhisker formation.
The second weight-loss window (250-300°C) is directly related to the nucleation and growth of iron oxide nanoparticles. A reaction temperature of 290°C was chosen to study the ligand effects on the nucleation and nanoparticle growth process based on TGA plot of iron oleate [16, 103] . This temperature is high enough to decompose all three ligands of the precursor, but it is still below the burst nucleation temperature ([300°C). At this temperature, different amounts of TOPO were used to alter the nucleation event. Interestingly, iron oxide nanoplates (*3 nm thick) were obtained with TOPO/OA *1.65/1. Figure 8a shows the TEM image of iron oxide nanoplates with a side length of *18 nm. This plate-like nanostructure was highly crystalline indicated by the lattice fringes of the HRTEM image (Fig. 8b) , and the ordered dot pattern of the fast Fourier transformation (FFT) image (Fig. 8b,  inset) . The HRTEM image was obtained with a 308 a-tilt angle, which confirmed the thickness of the thin nanoplates was about 3 nm. However, under a similar reaction condition, nanoflowers (*20 nm) were produced by simply increasing the TOPO to OA ratio five times (Fig. 8c) . The HRTEM image clearly indicated that the nanoflowers were composed of many small (*5 nm) iron oxide nanocrystals, which was also supported by the ring dot pattern of the FFT image (Fig. 8d) .
The magnetization versus applied field (M-H) curves of both samples showed large saturation fields ([1.5 Tesla), similar to that of typical small (\5 nm) spherical nanoparticles (Fig. 9) . The high-saturation magnetic fields indicated large surface areas of the nanostructures, leading to increased paramagnetic signal. Even though the nanoplates and nanoflowers have distinct morphologies, both samples have large surface areas. The high surface area was a result of the very thin morphology (*3 nm) of the nanoplates and the small crystalline grains (*5 nm) of the nanoflowers. The paramagnetic surface layer is from the surface capping molecules and the magnetically disordered spin of the surface atoms.
The formations of nanoplates and nanoflowers under similar reaction conditions suggested that capping ligands could be used to tailor the concentration of nuclei and subsequent nanoparticle growth. It was proposed that the nanoplates were formed following a diffusional-growth pathway, where C 2 H 5 O -, an impurity from precursor preparation, served as the third ligand and facilitated the formation of nanoplates. In contrast, at high TOPO concentration, the high nucleus concentration induced the formation of the iron oxide nanoflowers through aggregation of very small iron oxide nanoparticles.
Studies of nanowhiskers and nanoplates/nanoflowers suggested the importance of reaction temperature as the nucleation process at 250°C can be easily affected. Interestingly, by simply slowing down the nucleation process through step-heating processes (250°C-20 min, 320°C-30 min), well-defined iron oxide nanocubes can be obtained [22] . The design was to slow down the decomposition at 250°C, allowing for the formation of cubic ferrite nuclei, and then the heating at 320°C led to the nanocube growth on the preformed seeds. Figure 10 shows the TEM and high-resolution TEM images of the iron oxide nanocubes formed through the step-heating process. The Raman spectrum of iron oxide nanocubes in Fig. 10c shows the as-expected A 1g band at 671 cm -1 , corresponding to the vibrational stretching of the tetrahedral units, T 2g (2) [14] . The rationale for the aggregation process is that TOPO-capping ligands on the nanoparticle surfaces are dynamic (constantly attaching-detaching) at high temperatures because of their weaker binding to iron oxide surfaces [95] and the very bulky tails, which prevent them from forming a dense-packed layer on nanoparticle surfaces [78] . When the uncovered nanoparticle surfaces meet each other, the nanoparticles will start to interconnect, subsequently leading to the formation of nanoworms. In contrast to the 1:1 OA to TOPO ratio for nanosphere formation, over five times more TOPO molecules were needed to facilitate the aggregation process. In addition to the increased amount, TOPO was injected into the reaction around 300°C for nanoworm formation, rather than being added before the heating process. This step was designed based on the TGA analysis to influence the nanoparticle growth, but not the nucleation process [16, 103] . Figure 11a shows the TEM images of iron oxide nanoworms produced from a typical reaction, where some spheres can still be seen. The high-resolution TEM (HRTEM) images ( (Fig. 11d) . In contrast, the nanospheres before aggregation are superrparamagnetic.
The aggregation process was confirmed by the timedependent studies (Fig. 12 ) where samples were taken out of reaction at various reaction times (e.g., 1, 2.5, and 5 h). At 1 h, only a few of nanoworms were observed among mostly spherical nanoparticles (Fig. 12a) . By 2.5 h, the typical reaction time, significant amount of nanoworms were formed with some spherical nanoparticles (Fig. 12b) . After 5 h reactions, the nanoworms continuously grew in length to over 200 nm (Fig. 12c) . With the increasing reaction time, only the lengths of the nanoworms were found to change, while the diameter remained the same as that of the starting nanospheres. These experimental observations supported the hypothesis that the nanoworms were formed from the aggregation of nanospheres.
In summary, the detailed analysis of the iron oleate thermal decomposition behavior, based on TGA measurements, allowed for the rational design of synthetic processes for the preparation of iron oxide nanoparticles with well-defined sizes, shapes, and surface properties.
Self-assembly of large-area nanoparticle arrays
Convective self-assembly is often performed to organize a large quantity of nanoparticles in 3D space [114] [115] [116] . First, nanoparticle cores are often stabilized by surfactants and dispersed in a carrier fluid [117] . Then, as the carrier solvent is evaporated, the convective flow will drive nanoparticles in solutions to move toward the drying front, where the capillary force in the meniscus squeezes nanoparticles together for nucleation and growth of nanoparticle assemblies [118] . Typically, the convective self-assembly of nanoparticles often occurs at the air/liquid or air/solid interfaces [49, 118] . The former gives nanoparticles more freedom to adjust their positions during self-assembly, and the latter allows us to control the movement of the contact line of the drying front by the prefabricated features on the surface [48, 50, 55, 119, 120] . Self-assembly of nanoparticles can be affected by a variety of factors, including drying front movement, nanoparticle movement in solution, evaporation rate, and directions of carrier fluids, etc. Here, we discuss controlling nanoparticle self-assembly by manipulating the evaporation of carrier solvent and the movement of drying front [41, 55, 56] .
Interparticle interactions often play an important role in determining the spatial arrangements of nanoparticles [51] . After magnetic nanoparticles are brought closely together at the drying front by convective flow and capillary forces, magneto-static, van der Waals, steric, and depletion forces are the main forces that determine the final morphologies of the nanoparticle assemblies [42, 51, 52] . The dominant interaction between magnetic nanoparticles is determined by the sizes of nanoparticles [42] . Nanoparticles above a critical diameter, D sp , are magnetically blocked at room temperature for typical measurement times of 100 s; then the magnetization of individual magnetic nanoparticles is frozen in direction (in the coordinate frame of the nanoparticles) at room temperature [35, 75] , and the north and south poles of nanoparticles are successively aligned during self-assembly to minimize magneto-static energy [42, 52] . In this case, nanoparticle chains are often obtained. Here, we focus on the self-assembly of superparamagnetic nanoparticles (D \ D sp ), where van der Waals interactions dominate over magneto-static interactions [42, 51] . Strong van der Waals force is desired to assist nanoparticle assembly [121] , which makes it easier for nanoparticle ensembles with larger sizes and higher densities of nanoparticle cores. The number of surrounding nanoparticles is often maximized to increase van de Waals interactions and reduce the free energy of the system. In addition, it has been demonstrated that the interactions are much stronger between faceted nanoparticles, which can be taken advantage for nanoparticle assemblies [122, 123] . For example, large-area nanoparticle monolayers were formed by using cubic cobalt ferrite nanoparticles and using the modified self-assembly method in Ref. [55] , which is proposed for hard disk applications [124] . When a drop of nanoparticle solution is put on an open surface, carrier solvent evaporates along all possible directions. The concentration of nanoparticles at the drying front varies as the contact line retreats due to the variable evaporation rates and local concentrations at different positions and times. Due to this variation, nanoparticles are often clustered and distributed on the surface with gaps between them, such as the sample prepared by evaporating a nanoparticle solution on a TEM carbon film. Further, if the contact line of the evaporating solution is pinned, the evaporation will drive interior nanoparticles in solution to the drying front to deposit and form coffee stain rings [125, 126] . Monodisperse nanoparticles are often deposited layer-by-layer to build islands from a monolayer, to a bilayer, and then a multilayer. As the concentration of nanoparticles in solution increases, nanoparticle clusters will grow larger and thicker while the gaps between them gradually become smaller. By uncontrolled evaporation, no uniform and continuous nanoparticle assembly can be obtained over large areas, which is often necessary in many applications [38, 124] . To obtain high-quality nanoparticle assemblies, both evaporation direction and rate of carrier fluid should be carefully controlled [55] . Further, during growth, the nanoparticles should be driven steadily from interior solution to the drying front. By doing this, the nanoparticle concentration is approximately constant at the drying front when it moves so that the growth condition for nanoparticle assembly is almost the same at different times and locations to yield an uniform assembly [55] . Further, if the concentration of nanoparticles in solution is tuned properly to be below the critical value for formation of bilayers, monolayer of nanoparticles will form on the surface. However, the concentration should not be too low since the total number of nanoparticles determines the total area of the self-assembled monolayer(s) of nanoparticles [55] .
In summary, the self-assembly of superparamagnetic nanoparticles can be 'intrinsically' affected by shape, size, and bulk density of the nanoparticle cores [122, 124, 127] . It is also 'extrinsically' affected by the evaporation rate and direction of carrier solvent, movement of contact line, and concentration of nanoparticle [55] . To make a high-quality nanoparticle assembly, these intrinsic and extrinsic factors should be carefully considered and designed for a convective self-assembly process. In addition, it is also found that extra surfactants in the solution can also significantly affect the self-assembly process [55] . Further, the extra surfactant could also improve the mechanical strength of the selfassembled monolayers [128] [129] [130] . Finally, the carrier solvent should be carefully chosen. The solvent should be a good dispersant with proper evaporation rate [55] . Figure 13a shows the schematic experimental settings used to control the evaporation of carrier solvent for fabricating continuous ultra-large-area self-assembled monolayer of nanoparticles [55] . Here, D.I. water is used as subphase to give nanoparticles freedom to relocate during self-assembly [55] . Iron oxide nanoparticles are coated with OA and dispersed in a mixture solvent of toluene and hexane with volume ratio of 1:2. Toluene and hexane are chosen because they can disperse surfactant-coated nanoparticles well, and they have appropriate evaporation rates [55] . The concentration of nanoparticles in the mixture solvent is tuned to be able to cover an area on the order of centimeters but low enough to prevent the formation of bilayers or multilayers. A drop of nanoparticle solution is spread on top of the liquid subphase in a trough, which is then partially covered by a glass slide, as shown in Fig. 13a . The partially covered trough can reduce the evaporation of the carrier solvent. It also only allows carrier solvent to evaporate along one direction to the opening. By doing this, the growth rate and the direction of nanoparticle monolayer are controlled [55] . Hexane evaporates quickly at the opening, while toluene flows back from the drying front to the interior solution. Droplets containing nanoparticles were thus circulated from the interior solution to the drying front along the sidewall of the trough. By doing this, the nanoparticles in the interior solution are continuously driven to the drying front, and the extra nanoparticles at the drying front were brought back by the circulating flow to the interior solutions [55] . As a result, the nanoparticle concentration at the drying front is approximately kept constant so that nanoparticle monolayer can be continuously extracted from the mixture solution. Figure 14a shows the TEM image of large-area selfassembled monolayer of *12 nm monodisperse Fe 3 O 4 nanoparticles. After the carrier solvent has completely evaporated, a monolayer of iron oxide nanoparticles is floated on the surface of the subphase, which is then transferred to a substrate for further characterizations and applications, as shown in Fig. 14b . The area enclosed in (a) is magnified and shown in Fig. 14c , which shows a closely packed hexagonal monolayer of nanoparticles. Imperfections such as vacancies and edge dislocations are also observed in the nanoparticle monolayer, which minimize the free energy of the system [55] . The FFT of the monolayer in an area of *7 lm 9 7 lm in Fig. 14a is given in (d). The hexagonal pattern of the FFT indicates that all nanoparticles in this large area are aligned along a single crystal orientation. Lower magnification image of the monolayer is shown in the scanning electron micrograph (SEM) in Fig. 14b . The SEM overview shows that the monolayer is polycrystalline, but with long range order as shown in Fig. 14e . Figure 14b shows that the grains with different ''crystallographic'' orientations have different stripe patterns at lower magnifications, from which grain boundaries can be clearly identified [55] . The Fe 3 O 4 magnetic nanoparticles, black in solution, appear purple when they are self-assembled into monolayers and coated on the yellowish SiN x thin films on a silicon substrate, as shown in the inset of Fig. 14b . Further, the above selfassembly method can be used to fabricate monolayer of other surfactant-coated colloidal nanoparticles as well, such as gold nanoparticles [55] . It is worth pointing out that monodisperse nanoparticles (\*5 %) are needed to make crystalline monolayers with longer range orders [55, 131] . When one monolayer of nanoparticles is superimposed on another, nanoparticle bilayer forms with a rotation angle between the close packed directions of the two set of monolayers [55] . Figure 15a -d shows the TEM image of nanoparticle bilayers with different rotation angles. The FFT of the TEM image in Fig. 15d can be divided into two subsets of hexagonal patterns, which are indicated by the red and blue circles, respectively, in Fig. 15e , g. The inverse transformation of the FFT (IFFT) in Fig. 15e , g gives the images of the two monolayers as shown in Fig. 15f , h, respectively. The rotation angle of the bilayer is calculated by measuring the angle between the close packed directions of the two monolayers as shown in Fig. 15h . The rotation angles of the bilayer in Fig. 15a-d are 0°, 8°, 17°, and 20°, respectively. Moiré fringes can be clearly observed, and the period of the Moiré pattern decreases as the rotation angle increases, which is smallest at rotation angle of 30°due to the sixfold symmetry of the monolayer [132] . By rotating and superposing two dot arrays in computer, the nanoparticle bilayer and Moiré fringe can be simulated with corresponding rotation angles as shown in Fig. 15i -l, which is consistent with the real TEM image in Fig. 15a -d, respectively [55] . [55] Nanoparticle monolayers fabricated by the above technique are continuous and uniform over centimeter-length scales, and thus can be considered or used as granular nanoparticle thin films. These nanoparticle monolayer thin films are of great interest for fundamental investigations and use as functional layers in devices [38, 41, 133, 134] . They are also of interest for many other applications such as nanoparticle lithography [135] , discussed later in ''Nanoparticle lithography'' section. Besides the large-area 2D monolayer or bilayer, it is also often required to selfassemble nanoparticles into complex hierarchical structures [136, 137] , such as nanoparticle assembly arrays, where assemblies composed of *millions of nanoparticles are spatially organized in 2D arrays [56] . The combinations of lithographic techniques and convective self-assembly can be used to fulfill requirements of hierarchical selfassembly [43, 48, 50, 56, 119, 138] . Here the lithographic techniques have two important roles, namely, (1) to generate the first layer of the hierarchical structures on the substrates, and (2) affect the movement of the contact line by the lithographic features [48, 56] . The patterns can be generated by photolithography and e-beam lithography. Figure 16 shows an inverted pyramid hole arrays generated by photolithography, followed by wet chemical anisotropic etch. When nanoparticle solution evaporates on the generated hole arrays, the contact line will be pinned at the lithographic features, and nanoparticles will be driven along the meniscus to deposit in the holes by surface tension [48, 56] . As a result, nanoparticles will be preferentially deposited into the holes to generate nanoparticle assembly arrays [50] . However, when large numbers of nanoparticles are contained in each hole, it is nontrivial to fully and uniformly fill the hole arrays over large area [56] . Uncontrolled or improperly controlled evaporation of nanoparticle solutions often results in uneven filling of the hole arrays and inhomogeneous growth of nanoparticle assemblies [56] . Rapid evaporation will not give nanoparticles sufficient time to diffuse and reach their equilibrium positions, resulting in multiple nanoparticle assemblies in one hole and undesired massive deposition on the silicon wall [56] . Simple reduction of evaporation rate by slow pulling often results in partial filling [56] .
To generate uniform nanoparticle assembly arrays over large area, the evaporation of the nanoparticle solution on the patterned surface should be properly controlled [56] . First, the evaporation rate should be slow and steady to give nanoparticles sufficient time to move in the lateral directions toward the holes. Second, the evaporation direction should be controlled to allow nanoparticles to move only along the lateral directions to the drying front to feed the nanoparticle deposition in holes [56] . To satisfy these two conditions, a procedure as shown in Fig. 17 is designed and used for the fulfillment of the hierarchical self-assembly of nanoparticles [56] . A drop of colloidal nanoparticle solution was spread on the patterned substrate, which was previously put in a petri-dish. Afterward, a fluorinated polyether plate of low surface energy is then placed on top of the nanoparticle solution. A nanoparticle solution layer is formed and sandwiched by the patterned substrate and the polymer plate. The petri-dish is then partially covered by a glass slide, as shown in Fig. 17 . By doing this, the carrier fluid only evaporates toward the opening along the slit between the polymer plate and the substrate. In this process, the evaporation rate is reduced by the cover of polymer plate and the glass slide, giving nanoparticles sufficient time for movement. At the same time, the movement direction of nanoparticles in the carrier solution is also controlled by the evaporation direction of carrier fluid, which keeps driving nanoparticles in the solution reservoir to the drying front. As a result, the growth of nanoparticle assemblies in the hole can be continuously fed. After completion of evaporation, most nanoparticles are deposited in the holes, and sporadic nanoparticles deposited on the silicon wall are then removed by gentle polish [56] . Figure 18a shows a SEM image of pyramid nanoparticle assembly arrays over large areas. It is clear that the pyramid holes are completely filled by nanoparticles. No nanoparticles are found on the silicon wall by high-resolution image [56] . A focused electron beam was scanned along the green line as shown in Fig. 18a to perform energy dispersive X-ray spectroscopy (EDX) for element analysis. The corresponding concentration profiles of iron, cobalt, oxygen, and carbon are shown in Fig. 18b . The cobalt, iron, and oxygen signals are from cobalt ferrite nanoparticles, and carbon is from the surfactants coated on nanoparticles. The periodic concentration profile corresponds to the periodic structures of pyramid nanoparticle assembly arrays. The element mappings of cobalt and iron in Fig. 18d , e, correspond one-to-one with the SEM images in Fig. 18c . The large-area magnetic nanoparticle assembly arrays allow us to detect the magnetic behavior of nanoparticles in a single assembly by measuring the whole sample [56] . It is found that the magnetic pyramid nanoparticle assemblies can be easily magnetized along the fourfold symmetric axis [56] .
As shown above, convective self-assembly is a simple, effective and economical method to engineer the spatial organizations of nanoparticles, exemplified by the 2D monolayer of nanoparticles and 2D array of nanoparticle assemblies. For large-area nanoparticle assembly, it is critical to control the evaporation rate and directions of carrier fluid to achieve uniform deposition of nanoparticles across the whole process. The high-quality nanoparticle assemblies give us additional degrees of freedom in designing the properties of magnetic nanoparticles, which definitely will affect and extend the application of magnetic nanoparticles.
Fabrication of hybrid magnetic composites
The increasing demand for multifunctional materials has led to the development of new and sophisticated composite materials [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] . In particular, hybrid structures consisting of magnetic nanoparticles embedded in a polymer matrix have gained interest as a new class of smart materials that combine magnetic field responsive behavior with attractive mechanical properties [145-147, 150, 152] . To date, extensive research has been devoted to the development of high-performance magnetic polymer composites for diverse applications in structural materials engineering and the biosciences [146] [147] [148] 152] . Moreover, the development of these materials has drawn attention to the scientific challenges in understanding the underlying physics behind their novel magneto-elastic properties, which is complicated by the collective influence of a variety of factors including materials chemistry of the composite, nanostructure morphology, and interface interactions [148] [149] [150] . The study of structure-property relationships in magnetic nanoparticlereinforced polymer composites is rapidly growing but requires unique synthetic capabilities and high-end characterization tools since the performance of magnetic composite materials not only depends on its microstructure but also on the processing techniques and the influence of the microenvironment during specific applications. Elastomers represent an important class of soft polymeric materials that exhibit low elastic modulus [151] . When magnetic nanoparticles are mixed with an elastomeric polymer, such as poly(vinyl alcohol)-based hydrogel [152, 153] or silicone rubber [152] , the resulting magnetic polymer composite can demonstrate controlled stretching, contraction, and bending deformations under the influence of an external magnetic field. Tuning the orientation and magnitude of the external magnetic field can control the deformation motions and the variations in the composite material's tensile strength, compression, and shear moduli, thereby making them ideal materials for developing dampers in the automotive industry, rotating tools for machineries, and mixing pumps in microfluidic devices [147, 150] . Basically, there are two general types of magnetic nanoparticle-loaded elastomers: the first are isotropic magnetic polymer composites that have uniform spatial distribution of magnetic nanoparticle fillers, and the second are anisotropic composites characterized by uniaxially ordered filler nanoparticles (Fig. 19 ) [145] . An anisotropic system can be prepared by fabricating elastomers/magnetic nanoparticle composites under a uniform magnetic field (Fig. 19a) . The anisotropy manifests itself in the directiondependent elastic modulus (Fig. 19b) . The elastic modulus can be increased if the direction of the magnetically aligned nanoparticle chain and the compression force are parallel. This finding, demonstrated by Filipcsei et al., suggests that strong mechanical anisotropy can be affected by incorporating chains of nanoparticles [145] . The spatial distribution of the magnetic nanoparticles has a decisive effect on the stress-strain dependence of the composites. When the direction of the compressive force is parallel or perpendicular to the magnetic nanoparticle chain structure, a deviation from the ideal mechanical behavior can be observed. This kind of mechanical behavior can be described by the Mooney-Rivlin equation with C 2 \ 0:
where W is the work stored as strain energy, k is the elongation of the original sample, and C 1 and C 2 are the materials constants. Similarly, it has been recently demonstrated that by using superparamagnetic iron oxidecoated reinforcement particles, ultralow magnetic fields can be utilized to precisely control the position and orientation of reinforcing particles within the polymer matrix, to give rise to a myriad of properties including out-ofplane global or local increase in composite stiffness, strength, hardness, wear resistance, and shape memory effects [145] .
To facilitate the incorporation of magnetic nanoparticles into the polymer matrix, several well-known polymerization techniques have been optimized and utilized for grafting various types of polymer brushes on magnetic nanoparticles [154] [155] [156] [157] [158] [159] , which include grafting-to polymerization methods using click chemistry techniques [160] , ring-opening polymerizations [161] , and controlled radical polymerization methods [162] [163] [164] . In particular, the controlled radical polymerization approaches, such as reversible addition-fragmentation chain transfer polymerization (RAFT) and atom-transfer radical polymerization (ATRP), have been shown to produce well-defined and dispersed polymer-coated magnetic nanoparticles. Polymer brushes have been successfully grafted onto various types of nanoparticles using RAFT and ATRP methods, which facilitate the introduction of a large variety of polymers such as poly(methyl acrylate), poly(methyl methacrylate), poly(acrylic acid), and poly(N-isopropyl acrylamide) of controlled molecular weights on the nanoparticle surface [165] . In addition, through surface-initiated ring opening polymerization (ROP), polymer brushes such as poly-ecaprolactone and poly(lactic acid) have been successfully grafted and grown on the surface of magnetic nanoparticles without polymer branching or abrupt termination of the polymerization process [161] . Moreover, block-copolymers with alkyne-terminating groups have been grafted on the surface of magnetic nanoparticles containing azide functionality via Cu-catalyzed click chemistry techniques [160] .
The coating of polymer shells on the surface of magnetic nanoparticles has also made the construction of higher-order hierarchical structures possible. Using the seeded emulsion polymerization technique, clusters of magnetic nanoparticles have been encapsulated within polymer matrixes. Through adjustment of the concentration of the emulsifier, the size of the emulsion micelle containing monomers and magnetic nanoparticles can be controlled [166] [167] [168] [169] . With the introduction of an initiator and a crosslinking agent, the monomers are polymerized and crosslinked inside a stable polymer shell, which locks the cluster of magnetic nanoparticles in place [167] . The resulting magnetic nanoclusters have been shown to exhibit optimized MRI contrast enhancement and improved response in magnetic hyperthermia applications [167] . Magnetic composites made from thermoplastic polymers can also be fabricated using various processing methods, such as compression molding [170] , melt compounding [171] , solution casting [172] , and melt extrusion [173] . In the fabrication of magnetic thermoplastics, particle agglomeration has been a consistent challenge, and alternative approaches have been introduced by using core-shell magnetic polymer nanoparticles with increased stability to prevent aggregation [172] . Iron oxide nanoparticles have been incorporated into an ultrahigh molecular weight polyethylene (UHMWPE) matrix as a platform to study the effects of interparticle interaction on the AC magnetic field response of iron oxide nanoparticles. The general use of UHMWPE as a composite matrix remains a challenge due to difficulties in processing. The extremely high molecular weight of this polymer makes it unprocessable by conventional thermoplastic processing techniques, and dispersion of magnetic nanoparticle fillers has been a serious challenge due to the polymer's extremely high viscosity. With decreasing particle size, the ratio of surface/volume increases, and the surface properties of the nanoparticles become a major factor in influencing its interfacial properties and agglomeration behavior. Therefore, to adjust the composite material's processability and properties, tailoring of the magnetic nanoparticle surface as well as tuning of the interfacial layer between the particle and the polymer matrix is crucial. The degree of particle agglomeration can, however, be further influenced by utilizing dispersants, which strongly influence the composite rheology because of the reduction in interparticle friction. For example, Bin et al. have successfully prepared multiwalled carbon nanotube (MWCT)-reinforced UHMWPE using decalin and paraffin as MWCT dispersants and have observed high stiffness and electrical conductivity in the fabricated composites [174] . On the other hand, Rong et al. have grafted styrene monomers on the surface of 7-nmsized SiO 2 nanoparticles before mixing them with the polypropylene matrix [175] . This technique produced samples with no significant aggregation and, in addition, greatly increased the particle-polymer matrix interfacial interactions. It was also evident from the studies of Guoliang et al. that the liquid-solid mechanical dispersing method is better than the dry powder direct mechanical mixing approach in producing composites with better mechanical properties, owing to better particle distribution in the former method [176] .
Consequently, to produce magnetic UHMWPE composite films with good particle dispersity, a liquid-solid mechanical mixing approach was adapted to fabricate magnetic UHMWPE composites. A high-speed blade mixer was first used to blend the magnetite nanoparticles with UHMWPE in the presence of an organic solvent dispersant. This approach has been successfully utilized in the processing of Al 2 O 3 nanoparticle-reinforced PEEK polymer [176] and in carbon nanotube-reinforced UHMWPE [174] . To prepare magnetic composite films, the resulting UHMWPE and iron oxide magnetic powder blend was compression molded between layers of PTFE sheets and iron steel plates in a Carver Model laboratory press under seven metric ton of pressure (Fig. 20 ) [177] . In order to determine the optimal temperature for fabrication, the melting temperature of UHMWPE was evaluated using differential scanning calorimetry (DSC), and the oxidative degradation of the polymer matrix was examined using attenuated total reflectance-FTIR spectroscopy (ATR-FTIR). To ensure that the polymer is in its molten state for the fabrication process while maintaining minimal oxidative degradation, the optimal fabrication temperature was chosen to be 200°C. Comparing the mechanical properties of the magnetic polyethylene composite fabricated using the optimized liquid-compounding method to that of the composite fabricated using the typical dry mixing method, there is a significant increase in elastic modulus with the liquid-compounding method. This can be explained by the improved nanoparticle dispersity within the polyethylene matrix owing to the presence of the organic solvent during mixing (Fig. 21a) . The field-dependent magnetic properties of the uncompressed (prior to compression molding) and compression-molded magnetic nanoparticle-polyethylene composites containing 0.5 % Fe 3 O 4 nanoparticles were essentially unchanged during the processing step (Fig. 21b) . The magnetic hysteresis data obtained at 300 K reveal zero coercivity and remanence (inset, Fig. 21b ), which demonstrates that the magnetic nanoparticles are superparamagnetic at room temperature even after being embedded in the UHMWPE matrix. From these results, it can be inferred that the morphology and superparamagnetic properties of the nanoparticles were preserved in the composite film, indicative of the resiliency of the nanoparticles while being subjected to high-temperature and -pressure conditions during the compression-molding stage.
Using the liquid-solid processing method, different percentages of magnetic nanoparticles could be incorporated into the UHMWPE matrix (Fig. 22a) . As anticipated, improved heating profiles, which can be exploited for magnetic hyperthermia applications, were observed with increasing magnetic nanoparticle loadings upon AC field excitation (Fig. 22b) . However, the overall elastic modulus and tensile strength of the magnetic polyethylene composite decreased with the increasing nanoparticle loadings (Fig. 22c) .
To overcome this challenge, a hydrothermal carboncoating approach was employed to improve the polymeriron oxide nanoparticle interfacial interactions (Fig. 23a) . To form the carbon-coated iron oxide nanoparticles, antiferromagnetic FeO nanoparticles were used as co-reagents in the hydrothermal carbonization of glucose. The FeO nanoparticle and glucose mixture was treated under hydrothermal conditions for 2-12 h at 180°C (Fig. 23b ) [143] . During the HTC process, the FeO precursor nanoparticles slowly oxidized into ferrimagnetic Fe 3 O 4 nanoparticles, leading to enhanced magnetic dipole interparticle interactions that facilitated the formation of short length iron oxide nanoparticle chain like assemblies [143] . The resulting carbon-coated iron oxide chains were then blended into the UHMWPE matrix, and this has led to improved mechanical properties of the magnetic polymer composites (Fig. 23c, d) .
Similar to the behavior of ferrofluids at elevated temperatures, magnetic polymer composites exhibit superparamagnetic characteristics [145] , but in contrast to magnetic fluids, the positions of the magnetic nanoparticles embedded into the polymer are rigidly fixed and particle motion is hindered. In magnetic polymer composites, the nanoparticles are trapped by the polymer network; therefore, the Brownian rotation is restricted, and the Néel relaxation is the dominating magnetic relaxation mechanism. Assuming that the particles do not interact, the magnetic behavior of the superparamagnetic material can be described by the Langevin function [5] . As such, the magnetic UHMWPE composite is a good platform for studying magnetic relaxation effects that de-couple the influence of Brownian motions. Surface engineering of nanoparticles A nanoparticle must be stabilized with capping molecules to reduce the surface energy and maintain its nanoscale size; otherwise, aggregation will occur. Beyond the stabilization, the capping molecules are critical to their applications. For instance, the water solubility and surface functionality of nanoparticles are key parameters affecting their interactions with biological systems. The surface coating, in particular, directly affects nanoparticle cellular uptake [69] , biodistribution [70] , blood circulation [71] , and metabolism [72] (see ''Pharmacokinetic pathways of iron oxide nanoparticles'' section). As discussed in previous sections, the high-quality iron oxide nanoparticles with controlled size distribution, crystallinity, and magnetic properties are normally produced in organic solvents at high temperatures [87] [88] [89] [90] [91] . Therefore, surface engineering is essential to achieve nanoparticle water solubility as well as further conjugation and functionality for biomedical applications. The as-synthesized iron oxide nanoparticles, such as the nanoparticles prepared by the ''heat-up'' method (see ''Size and shape control of iron oxide nanoparticles'' section), are only soluble in organic solvents, and further surface modification is necessary for biomedical applications. Among various surface-functionalization strategies, the ligand exchange method has been highly attractive, because it removes the original hydrophobic coating and subsequently reduce potential toxicity effects on biological systems.
Introducing a weakly binding ligand, such as TOPO molecules in the heat-up synthesis method, on the nanoparticle surface was critical to ensure effective exchange [92] . Various molecules have been used to replace the surface hydrophobic coatings, such as polyethylenimine (PEI), polyacrylic acid (PAA), and glutathione (GSH). These molecules not only provided water solubility to the nanoparticles, but also offered carboxylic acid (-COOH) or amino (-NH 2 ) groups for further biomolecule conjugation. The biomolecule conjugations to the nanoparticles with carboxylic or amino groups are normally done via linker chemistry such as carbodiimide (EDC) chemical linker and N-hydroxylsuccinimide (NHS) ester crosslinker. Even though chemical linker conjugation is effective, the chemical linker approach suffers several disadvantages. First, special reaction conditions are normally required for effective conjugation, such as acidic condition (pH 4.5-5.5) in adapting the carbodiimide (EDC) chemical linker, basic condition (pH 7.2-8.0) at low temperature (4°C) with the use of a N-hydroxylsuccinimide (NHS) ester crosslinker, and reducing condition for maleimide chemistry. Second, low conjugation efficiency is always a concern because of competing reactions. For example, the EDC linker directly links carboxylic acid and amino groups, for conjugating molecules with multiple carboxylic acid and amino moieties (e.g., proteins), EDC chemistry always causes cross conjugation, thus, significantly decreasing the conjugation efficiency. Finally, Besides the molecular linker chemistry, specific recognition based on biotin-streptavidin is another common strategy [178] . Biotin-avidin interaction requires prior attachment of biotin molecules on the nanoparticles. The biotin-labeled nanoparticles will react with any biotinbinding protein, reducing the specificity. In addition, biotin is a natural biological molecule, causing a big concern about the specificity and background effects when involving biotin-rich tissues and extracts (e.g., brain, liver, milk, or eggs) 2 [179] . Recently, catechol surface conjugation has attracted much attention because catechol can be easily activated by raising the solution pH and the activated catechol groups can directly interact with biomolecules with no need of chemical linkers [64, 93] . The catechol groups were introduced onto iron oxide nanoparticle surfaces by using dopamine as an exchange ligand, where the amino group of the dopamine molecule attach to the iron oxide nanoparticle surfaces, leaving the catechol group out (Fig. 24) . The catechol groups on the nanoparticle surfaces can be easily oxidized into dopamine quinone at higher pH ([8.5), creating an active surface for further conjugation. The activated dopamine groups will allow for the direct conjugation of biological molecules containing amino and/ or thiol groups through Michael addition and/or Schiff base formation (Fig. 24) [180, 181] . Figure 25a shows the TEM image of dopamine-coated iron oxide nanoparticles in water. The presence of dopamine on the nanoparticle surface and the subsequent [143] activation were studied using FTIR (Fig. 25b) . Compared to that of the free dopamine, the FTIR spectrum of dopamine-coated nanoparticles showed several band shifts related to the primary amine group. The two -NH 2 stretching peaks of the free dopamine in the range of 3200-3400 cm -1 became a single broad peak at 3327 cm -1 after interacting with iron oxide nanoparticles. This broad peak is likely merged with the hydroxyl stretching band in the similar region. After interacting with iron oxide nanoparticles, the dopamine -NH 2 bending (1577 and 1469 cm -1 ) merged together with the -C=C-stretching in the range of 1460-1617 cm -1 and a much broader peak was observed. Further, the band of the -NH 2 wagging (815 cm -1 ) [182] shifted to a lower wavelength, another indicator of the attachment of amino groups to the nanoparticle surfaces.
The characteristic band of the -C-O stretching (1282 cm -1 ) remain unchanged before and after the attachment. After catechol group activation at pH 8.5, the IR spectrum of the activated nanoparticle surface exhibited a broad band at 1650 cm -1 , the characteristic of -C=O band in quinone structure [183] . The disappearance of the characteristic band of -C-O at 1282 cm -1 is another indicator of the dopamine oxidation. The oxidation process was also monitored with UV-Vis spectroscopy (Fig. 25c) . Because of the strong absorption of iron oxide nanoparticles, the absorption of the oxidized dopamine molecules was not well resolved. However, the typical absorption peak (409 nm) of the oxidized dopamine was clearly visible in the detailed scan (Fig. 25c, inset) .
To test the conjugation efficiency of the activated dopamine surfaces on nanoparticles, two model systems Fig. 24 A schematic drawing to illustrate the conjugation process Fig. 25 a TEM image of the dopamine-coated iron oxide nanoparticles (10 nm), b FTIR spectra of free dopamine, dopamine-coated, and activated dopamine-coated nanoparticles, and c time-dependent UV-Vis spectra of dopamine-coated iron oxide nanoparticles after activation. Copyright Ó American Chemical Society 2012 [64] were utilized, bovine serum albumin (BSA)-coated fluorescent Au nanoclusters and anti-GD2 antibody [64, 93] . The fluorescence emission of the BSA-coated fluorescent Au nanoclusters is also a quick tool to evaluate the conjugation process, while the antibody conjugation assesses whether the conjugation process will affect the biological activities of the conjugating molecules. For both systems, the conjugation experiments were performed by simply mixing the nanoparticles with activated surfaces with either BSA-Au nanoclusters or anti-GD2 antibody. The conjugated nanoparticles were then magnetically separated out of the solution, washed twice, and then and re-dispersed in water or buffer. Figure 26 shows the fluorescent emission and excitation plots of fluorescent Au nanoclusters after being conjugated on iron oxide nanoparticles surfaces. The intense fluorescence of the conjugated structured indicated the effective conjugation between BSA and the activated dopamine surfaces. Under UV irradiation, the integrated structure showed bright red color, and the same sample was also highly responsive to a magnet, which also suggested the successful conjugation. The small fluorescent nanoclusters under bright TEM were barely seen, but the high-resolution TEM image of a typical integrated structure showed the presence of a single nanocluster on an iron oxide nanoparticle surface (Fig. 26c) . Further, the conjugated nanoclusters were clearly observed in the darkfield image (Fig. 26d) . Both the highresolution TEM observation and the darkfield TEM image also suggested the effective conjugation of BSA-Au nanocluster to the nanoparticle surface.
A great concern for any biomolecule conjugate is whether the conjugation process affects the biological activities of the conjugated molecules. Subsequently, the catechol conjugation method was evaluated by the anti-GD 2 antibody, which specifically recognize GD2 disialoganglioside, an antigen expressed on neuroblastoma cancer cells, most melanomas and a large fraction of small cell lung cancers and other tumors of neuroectodermal origin [184, 185] . Figure 27a shows the negative stained TEM image of the antibody conjugated iron oxide nanoparticles, where antibodies were shown as lighter shells around the nanoparticles. The variation in the shell thickness was due to the different orientations of the antibodies on nanoparticle surfaces. The tiny dark spots around the nanoparticles were from the staining solution, where possible undissolved uranyl acetate stain or lead carbonate precipitation from lead citrate stain absorbed CO 2 from air.
In addition to the TEM visualization, the antibody conjugation was also supported by the zeta-potential shift of the nanoparticles (-44 eV to -34 eV) and hydrodynamic size change (24-34 nm) (Fig. 25b, c) . The presence of the protein characteristic amide I (1633 cm -1 ) and amide II (1520 cm -1 ) bands clearly suggested the attachment of antibodies. After conjugation, the amine or thiol groups normally attached to the fourth position adjacent to a hydroxyl group through Michael addition and the quinone shifted back to hydroxyl groups. This process was supported by the IR spectrum of antibody-conjugated nanoparticles, where hydroxyl and its C-O bands at 1065 and 1005 cm -1 were clearly seen, compared with the strong -CH=CH-ring breathing peak at 956 cm -1 (Fig. 26) . In fact, the IR bands in the range of 900-1100 cm -1 of the antibody conjugated nanoparticles were very similar to the dopamine-coated nanoparticles before oxidation. After conjugation, the targeting efficiency of the antibodies on nanoparticles was evaluated on GD2-positive neuroblastoma cells (CHLA-20) and normal fibroblasts. CHLA-20 neuroblastoma cells have a high level of expression of GD2 antigen on the cell surface, while normal fibroblasts do not express the GD2 receptor, serving as a suitable negative control [186] . The localization of the nanoparticles on CHLA-20 cell surface was visualized by fluorescence microscopy using green-fluorescent Alexa 488-labeled antihuman IgG antibody. The lack of green fluorescence after the treatment of cells with unconjugated nanoparticles and antihuman IgG antibody (Fig. 28a) indicated the absence of a nonspecific reaction of the detection system used. Remarkably, the sharp green shell around the cell surface (Fig. 28b) suggested the high level of binding of the antibody-conjugated nanoparticles to GD2-positive cells. In contrast, the antibody-conjugated nanoparticles did not bind to GD2-negative cells (such as normal fibroblasts, Fig. 28c, d) , indicating their high specificity of recognizing of GD2 receptors.
To confirm the co-localization of the nanoparticles with antibody, Prussian blue iron staining was performed on CHLA-20 cells treated with conjugated and unconjugated nanoparticles. CHLA-20 cells treated with unconjugated, dopamine-coated nanoparticles only showed occasional big blue spots from nanoparticle aggregates (Fig. 28e) . In contrast, the cells treated with antibody-conjugated nanoparticles showed clear blue shells around the cells, suggesting the presence of the nanoparticles around the cell membranes (Fig. 28f) . In conjunction with the fluorescent microscopy image, this observation suggested the co-localization of nanoparticles and antibodies.
Specific targeting is a key step to realize the full potential of iron oxide nanoparticles in nanomedicine. Facile and effective conjugation of the targeting molecules onto iron oxide nanoparticle surfaces is critically important. The uniquely designed catechol conjugation allows for easy attachment of bioactive molecules onto iron oxide nanoparticles without the need for any type of chemical linkers and maintains the activity of the attached biomolecules. Eliminating the use of chemical linkers significantly simplifies the conjugation process, reduces the requirements of well-trained personnel, and increases the efficiency of the conjugation. Importantly, this conjugation method can be effectively extended to other molecules.
Emerging applications and considerations

Nanoparticle lithography
For applications such as the proposed bit patterned magnetic media [187] [188] [189] , fabrication of dense nanopatterns with feature size of \20 nm and spacing of a few nanometers is required [41, 190] . Electron beam (e-beam) lithography is problematic to generate small (\10 nm) and dense nanopatterned arrays, where forward scattering of electrons in the resist often broaden the features, and the earlier written features would be affected by latter e-beam writing for dense structures [191, 192] . Besides the technical hurdles, e-beam lithography as a serial process is also very uneconomical and time consuming [193] . Block copolymer self-assembly is proposed and used as an alternative technique to generate these small and dense nanopatterns, which is then transferred into the underlying functional layers [194, 195] . However, as the feature size gets smaller, the driving force for block copolymer self-assembly will be greatly reduced [196] . Further, the self-assembled block copolymer is often a mixture of different morphologies [197] . As shown in self-assembly section, large-area monolayer of nanoparticles can be made by designed convective self-assembly at and Alexa 488-antihuman IgG antibody, and Perls staining using Prussian blue reaction detecting iron for (e) unconjugated; and (f) antibody-conjugated iron oxide nanoparticles [93] the air/liquid interface with colloidal nanoparticles [55] . These nanoparticle arrays are dense and for monodisperse nanoparticles, exhibit good long range order. The feature size is *10 nm, and the edge-to-edge distance is *2 nm. As a result, the self-assembled monolayers of nanoparticle is proposed as the 'etch' mask for nanofabrication of 2D dense arrays with feature size \10 nm [41] . Unlike the microsphere particle lithography where the empty spacing between particles is large enough for etchants to penetrate through [120] , etchants can hardly reach the underlying films through the *2 nm spacing between nanoparticles, which is filled with surfactants. The surfactants between nanoparticles can be removed by oxygen plasma. However, it often results in cracking in the ordered monolayer of nanoparticles due to moment transfer from plasma [198] . Although electron treatment can mitigate the cracking, the effect is limited. Further, it is difficult for oxygen plasma to burn the surfactant through to the substrate due to the aspect ratio-dependent etch rate [199] . As a result, instead of using nanoparticle as etching masks, a new etching processing should be developed to transfer the nanopattern of selfassembled monolayer of nanoparticles into the underlying materials.
Electron irradiation can turn surfactants into hydrogenated amorphous carbon [200, 201] , which is inert for fluorinated etching process [202] . Hence, surfactants can be used as resist material for e-beam lithography in siliconbased etching [201] . The surfactants around nanoparticle cores, a barrier for nanoparticle mask etch, can be used to transfer the nanopatterns of nanoparticle monolayers by e-beam treatment. Instead of a focused e-beam as in e-beam lithography, the e-beam was spread over large areas to treat all surfactants at one time [135] . By combining self-assembly of nanoparticle and electron treatment, dense and small hole arrays can be fabricated over large area in a parallel process [135] . Figure 29 shows the pattern transfer process using e-beam treatment and fluorinated reactive ion etch (RIE) [135] . The self-assembled monolayer of iron oxide nanoparticles was first treated by e-beam irradiation to turn the surfactant between and on top of nanoparticles into amorphous carbon, as shown in Fig. 29a, b . The surfactants underneath nanoparticles are slightly irradiated due to the shielding from nanoparticles. Afterward, the iron oxide nanoparticle cores were dissolved by hydrochloric acid to leave an amorphous carbon fence on the silicon substrates, as shown in Fig. 29c . The SEM image of the hole arrays of amorphous carbons is shown in Fig. 29g . CF 4 RIE was used to deepen the holes and transfer the pattern into the silicon substrate. The SEM image of the hole arrays in the silicon substrate is shown in Fig. 29h . The nanopattern has been successfully transferred from the self-assembled monolayer of nanoparticle into the silicon substrate by nanoparticle lithography [135] .
The pattern transfer fidelity is excellent as shown in the SEM image in Fig. 30 . The large grain sizes of selfassembled monolayers of the nanoparticles have been successfully transferred to the hole arrays in the silicon substrate, as shown in Fig. 30a . The hexagonal pattern and the long range order of the hole arrays can be clearly resolved in the SEM image in Fig. 30b , which is magnified from the enclosed area in Fig. 30a . Figure 30c shows the cross section of the hole arrays. The hole size is *10 nm, and the pitch is *15 nm. The depth of the holes is *10 nm. The dense and small hole arrays have been fabricated by the nanoparticle lithography technology. The polycrystalline structures of the self-assembled nanoparticles have also been transferred as shown in Fig. 30d . Different grains show different stripe orientations and periods, which can be used to differentiate the grain boundaries [135] . The profiles of the holes can be clearly discerned in the tilted SEM image in Fig. 30e . The curvature of a surface would significantly affect the surface and interface energy [203] , which can affect the morphologies of deposited thin films. When gold thin film was deposited on the hole arrays, it is found that gold atoms, originally deposited on the silicon wall, would automatically diffuse toward and fill the holes, resulting in gold nanoparticle arrays on the silicon substrate, as shown in Fig. 31 [135] . The diffusion is driven from convex to concave surface to minimize the surface energy of the system [203] . As the gold thin films grow thicker, gold nanoparticles become bigger with smaller gaps. Besides, the pitch of the gold nanoparticle arrays remains the same [135] . Unlike the nanoparticle arrays fabricated by selfassembly, the gold nanoparticle arrays on the hole arrays have tunable interparticle distances, which might affect their optical properties [204] . Nanoparticle lithography is very competitive over other lithography techniques to fabricate dense arrays with feature size \10 nm. Since the development of nanoparticle lithography is still in its early stage, many technical hurdles should be solved before it can be practically used. The dense arrays are currently transferred onto the silicon substrate by nanoparticle lithography. However, it is desired, although very challenging, to transfer the nanopattern of the self-assembled nanoparticles into functional materials, such as perpendicular FePt thin films. Besides antidot arrays, techniques should also be developed to fabricate dot arrays by nanoparticle lithography.
Magnetic particle imaging
MPI is an emerging tomographic imaging technique based on the magnetic relaxation of superparamagnetic iron oxide [135] nanoparticles [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] . In MPI, the large magnetic moment of the nanoparticles is directly probed rather than simply detecting its indirect effect on the proton relaxation, as in the case with MRI [210] . As such, MPI is fast, quantitative, and features good spatial resolution; a combination that is difficult to realize in the utilization of magnetic nanoparticles in MRI applications [210, 214] . Furthermore, unlike in MRI or in magnetorelaxometry imaging, MPI instrumentation has the potential for being relatively inexpensive because it does not require costly superconducting magnet or SQUID detectors to achieve high sensitivity [210] .
In MPI, the magnetic nanoparticles are subjected to an oscillating magnetic field and subsequently show a nonlinear magnetization response. During this process, there are two types of relaxation mechanisms that can affect the alignment of the nanoparticle's magnetic dipoles. Either the magnetic nanoparticle itself undergoes a physical rotation, (Brownian rotation), or the magnetic moment can rotate in a fixed nanoparticle (Néel rotation). The Néel relaxation time, neglecting the applied field amplitude, can be computed by
, where K A is the anisotropy constant, V is the nanoparticle core volume, and k B and T are the Boltzmann constant and temperature, respectively. On the other hand, the Brownian relaxation can be computed by s B = (3gV H k B -1 T -1 ), where g is the viscosity of the fluid and V H is the hydrodynamic volume of the nanoparticles. The shorter relaxation time will dominate the behavior of the system. Moreover, the transition frequency between Néel and Brownian will depend on the nanoparticle size and anisotropy, and the viscosity of the medium.
In its very basic form, MPI applies a time-dependent magnetic field (drive field) to change the magnetization of the nanoparticles using transmit coils. In order to detect the change of the magnetization, the magnetic flux density is evaluated by measuring the voltage induced using appropriate receive coils. Due to the nonlinear relationship between the magnetization and the external field, the nanoparticles produce an MPI signal at both the fundamental frequency, and also at higher harmonics [215] . The harmonic signal is linear with the nanoparticle concentration by simple Fourier transform: S n = Fourier {u(t)}; u(t) a -c {dM(t)/dt} where, S n is the magnetic nanoparticle harmonics, u is the voltage signal measured in the receive coils, c is the concentration of the magnetic nanoparticles, and M is the magnetization of the nanoparticles. The generation of higher-order harmonics for a nonlinear magnetization curve can be mathematically expressed by expanding the Langevin function into a Taylor series. Since all even derivatives of the Langevin function have a zero crossing point, at which the Taylor series is expanded, the even harmonics are absent, and only odd harmonics are seen in the signal spectrum [215] .
For spatial encoding, an additional magnetic field gradient is superimposed onto the drive field such that a fieldfree point is established within the volume of interest [204-206, 208, 209] . Only particles located in the field-free point (FFP) contribute to the desired signal in the receive coils. Particles outside the FFP are saturated and do not show any further re-magnetization dynamics upon excitation by the drive field. In order to understand the behavior of the superparamagnetic probes in the various applied magnetic fields, a suitable model is needed. It has been shown that the simple Langevin theory of magnetism is capable of describing, to the first order, the important features of the imaging process [207, 209, 210] .
To date, MPI studies have been effectively employed to image the real time movement of magnetic nanoparticles through a beating mouse heart [205] . This preclinical result demonstrated the potential of MPI as a valuable tool in cardiac imaging and cardiovascular disease diagnosis. Moreover, several groups have demonstrated that stem cells can be loaded with superparamagnetic iron oxide nanoparticles and be subsequently investigated using MPI [214] [215] [216] . With MPI having an anticipated low detection limit, it is conceivable that an MPI system could track a small number of stem cells and propel the development of this area of biomedical research. In addition to stem cells, red blood cells have also been labeled with superparamagnetic iron oxide nanoparticles, with the objective to use human erythrocytes as nanoparticle carriers for MPI tracers to conduct in vivo monitoring of blood circulation. A study Fig. 31 The gold nanoparticle arrays generated by depositing gold thin film onto the nanohole arrays. The different sizes of gold nanoparticle in (a) and (b) are due to the different amounts of deposited gold atoms. Copyright Ó American Chemical Society 2012 [135] J Mater Sci (2016) 51:513-553 537
by Markov et al. [217] used red blood cells loaded with Resovist and Sinerem to generate the MPS signal. In addition to exhibiting an MPI signal, the magnetic tracerloaded red blood cells evidenced a long blood half-life, which makes them especially suitable for imaging of the circulatory system. Various applications of MPI, including cardiovascular imaging, sentinel lymph node biopsy (SLNB), and stemcell tracking, have been actively pursued in various research groups [33, 65] . Moreover, the potential application of MPI in examining composite polymer biomaterials have been explored. In particular, we are working toward the use of MPI as a unique tool to characterize the in situ wear debris formation of magnetic polymer nanocomposites based on UHMWPE, which is used heavily in the fabrication of artificial joints (Fig. 32) [177] . The incorporation of superparamagnetic iron oxide nanoparticle inclusions into UHMWPE-based composite materials will enable us to attain magnetic signatures that can be exploited for the in situ monitoring of the wear debris formation of the material in various chemical and biological fluid environments. An improved spatio-temporal assessment of the structural integrity of the polyethylene material used in implants that is subjected to mechanical and chemical stresses will provide valuable information on the material's durability, and can help predict its wear and degradation over time. This capability has the potential to dramatically improve implant assessment and development and significantly reduce costs related to the replacement of failed prostheses.
Magnetic-guided drug delivery
The use of magnetic nanoparticles in biomedical research was pioneered by Gilchrist in 1956 when he utilized their induced heating for the treatment of lymph nodes near cancer sites [218] . A few years later in 1963, Meyer described how one can exploit magnetic targeting to localize iron oxide nanoparticle-based drug delivery systems for targeted therapeutic applications [219] . Over the years, different drug delivery vehicles have been developed that continue to take advantage of the unique properties of magnetic nanoparticles [220] [221] [222] [223] .
The design and assembly of magnetic drug delivery structures range from the surface modification of single particles to the adaptation of hollow and hybrid structures decorated with magnetic nanoparticles (Fig. 33) . Magnetic nanoparticles can be synthesized with a core-shell structure upon coating with silica [224] , gold [225] , or a polymer to allow for easy functionalization and loading of drugs [152, 166] . Polymeric micelles structures consisting of hydrophilic outer shells and hydrophobic inner shells can be loaded with magnetic nanoparticles and active drugs inside the microcapsules through simple solvent evaporation methods. The size of the polymeric micelles can be controlled by adjusting the concentration of the amphiphilic block-copolymer used during the synthesis, thus providing flexibility on the loading of drug molecules [166] . In addition, various magnetic polymer nanostructures fabricated with thermoresponsive polymers can facilitate controlled release of drug molecules using magnetic hyperthermia effects [152] . Hollow nanostructures also provide an advantage for drug delivery due to the voids in the structure and its high drug loading capacity. Magnetic hollow nanoparticles can be directly synthesized through co-precipitation of aqueous metal precursors or a galvanic replacement reaction on pre-synthesized metal oxide nanoparticles [226, 227] . Along this line, porous FePt microstructures were synthesized using cationic poly (diaryldimethylammonium chloride) (PDDA) as a sacrificial template. After loading with doxorubicin (DOX), in vitro treatment with applied alternating magnetic field (AMF) excitation showed above 70 % retardation in gastric cancer and lung cancer cell growth [228] .
Magnetic nanoparticles have also been used to decorate other drug delivery vehicles for magnetic guidance. For example, magnetic nanoparticle decorated carbon nanotubes have been shown to be an effective platform for delivering anticancer drugs. Chen et al. have fabricated carbon nanotubes with Fe 3 O 4 nanoparticles and the AMF treatment at the therapeutic site increased the drug efficacy up to two times, demonstrating that adding magnetic features in the drug delivery system can improve treatment outcome and reduce dosage of anticancer drugs used during therapy [229, 230] . In addition to the unique structures that allow for high loading of drugs and localized treatments using an external magnetic field, fabricated hybrid magnetic nanostructures are also compatible with most drugs used for targeted therapy. For example, drug molecules like DOX and paclitaxel (PTX) are used in anticancer therapy and are most commonly used in magnetic-guided drug delivery studies [220] . Antibiotics such as tetracycline, penicillin, and ciprofloxacin have also been incorporated into magnetic drug delivery vehicles to deliver antibiotics for localized treatments at infected sites [227, 232] . Radioisotopes have also been delivered using magnetically guided vehicles for anticancer therapy. Magnetic microspheres with the b-emitter 90 Y were shown to localize in tumor areas that resulted in complete disappearance of more than half of the tumors treated [221, 233] .
Other than the ability to localize drugs at the diseased sites, magnetic nanoparticles have also been employed to design drug delivery vehicles with modulated drug release capacities through controlled excitation with an external magnetic field. Langer's group has demonstrated an increase in drug release in polymer nanocomposites loaded with iron oxide beads under AMF excitation. In their study, they have demonstrated that the movement of the iron oxide beads upon AMF excitation produces ''microcracks'' in the polymer matrix that then enables the release of the drug molecules entrapped in the nanocomposite. This method has been proven to be effective in the selective release of drug molecules with large molecular weights, which have slow diffusion rates [144, 234] . Implantable magnetic-modulated hemispherical drug delivery devices were also designed to enhance the drug release rate of large drug molecules under magnetic trigger. Applying a similar theory, hollow and porous silica nanospheres containing clusters of iron oxide nanoparticles and DOX have been fabricated. In the absence of an applied AMF, the DOX can be released through the pores of the silica shell via diffusion. However, the AMF can induce magnetic hyperthermia effects, thus increasing the drug release rate (Fig. 34) [144] . Magnetic-triggered drug release has also been applied in nanostructures composed of flexible magnetic nanochains and drug-filled liposomes. The flexibility in the magnetic nanochains allows oscillation movements in the magnetic nanoparticles under the exposure to a radiofrequency field. Such oscillation movements can be transferred to the liposome filled with DOX and cause it to burst and achieve drug release ondemand [235] .
Superparamagnetic iron oxide nanoparticles have also been utilized for dual therapeutic and diagnostic functionalities for theranostic applications. Jain et al. fabricated iron oxide nanoparticles coated with OA and Pluronic F-127 that were subsequently loaded with the cancer drugs DOX and PTX [236] . They reported that the drugs could be loaded efficiently into the magnetic nanoparticles individually or in combination (74-95 %) . At the same time, the drug-loaded magnetic nanoparticles showed T 2 relaxivities comparable with that of Feridex IV but lower than that of bare magnetic nanoparticles. MRI-guided drug delivery using pH-responsive magnetic polymer nanocomposites has also been reported. A nanodrug carrier that specifically responds to the lower pH of extracellular cancer cells (pH 6.5-7.2) was fabricated by Lim et al. [237] . In their work, MnFe 2 O 4 nanoparticles and DOX were encapsulated in a pyrene-polyethylene glycol derivative using a nanoemulsion method. DOX forms strong pi-pi interactions with pyrene under physiological conditions (pH 7.4), but these interactions become weaker when DOX is protonated in acidic conditions like that of intracellular cancer cells (pH 5), which leads to drug release. MRI was used to see the distribution of the drug in the tumor cells. 
Magnetic resonance imaging (MRI)
MRI is a powerful, noninvasive tool for imaging tumors and monitoring therapy [238] . Clinically, contrast agents are routinely administrated to enhance image contrast for better resolution [239, 240] . Spherical iron oxide nanoparticles were traditionally utilized as negative (T 2 ) MRI contrast agents, which generate a darker (T 2 -weighted) image by shortening the transverse relaxation time (T 2 ) [27, 241] . Iron oxide nanoparticles have limited clinical use as negative (T 2 ) contrast agents, because these nanoparticles can only passively accumulate in the liver or spleen [242, 243] . In addition, signal attenuation after T 2 contrast injection is susceptible to misinterpretation due to other potential sources of signal voids [244, 245] . The currently available positive (T 1 ) contrast agents are primarily gadolinium (Gd) complexes, which generate a brighter (T 1 -weighted) image. Unfortunately, the use of Gd-based contrast agents has raised concerns about nephrogenic systemic fibrosis (NSF) in patients with acute kidney injury, severe renal disease, and liver transplant [246] . Recently, there is a growing interest in generating positive contrast with iron oxide nanoparticles through the alteration of imaging techniques. Several MR techniques for positive contrast imaging with iron oxide nanoparticles have been explored [247] , such as susceptibility-weighted imaging [248] and phase gradient imaging [249] . Recently, ultrasmall spherical iron oxide nanoparticles (*3 nm) were shown to generate positive MRI contrast in mice under standard imaging protocols [28] . Therefore, it is feasible to develop T 1 contrast agents for standard clinical scanners by simply adjusting the properties of the nanoparticles. The potential of using ultrasmall spherical iron oxide nanoparticles (\5 nm) as T 1 contrast agents has been demonstrated by several research groups [250] [251] [252] [253] . The rationale of using ultrasmall iron oxide nanospheres as T 1 contrast agents is that the strong surface effects lead to strong paramagnetic properties. The high surface areas also enhance the water diffusion around the nanoparticles. The strong paramagnetic property and large surface area for water diffusion make ultrasmall nanospheres good candidates for T 1 MRI contrast agents. In addition to generating positive contrast agents, 3 nm ultrasmall spheres also showed high r 1 relaxivity and increased blood circulation time [28] . The in vivo mouse study also suggested that the ultrasmall iron oxide nanospheres enabled high-resolution blood pool T 1 -weighted MR images of various blood vessels with size down to 0.2 mm. Figure 35 shows the T 1 -weighted MR images of a mouse circulation system. The positive enhancement of the blood vessels remained for 1 h, indicating the long circulation time. Both the positive enhancement and the long blood circulation time are very important for clinical MR imaging.
Ultrasmall spheres are always associated with aggregation issues because of the high surface energy [250] . In addition, small nanoparticles (\8 nm) generally have fast renal clearance and tend to escape from blood circulation [254] . Similar to the rationale of ultrasmall spheres, we recently demonstrated that ultrathin nanowhiskers can be used as effective T 1 contrast agents as well. The extremely small diameter (*2 nm) of these nanowhiskers led to very high surface-to-volume ratios. The iron oxide nanowhiskers were prepared using our previously published procedure by decomposing the iron (III)-ligand complex at 150°C with slight modification [16] . Specifically, oleylamine was introduced as a co-ligand during precursor preparation with oleate-to-oleylamine ratio of 2:1 [95] . This modification allowed producing iron oxide nanowhiskers with a more uniform diameter and length. Figure 36 a shows a TEM image of the ultrathin iron oxide nanowhiskers (about 2 9 20 nm) from a typical reaction. The high-resolution TEM image (inset) indicated the crystalline structure and small diameter of these nanostructures. These nanowhiskers showed a very strong paramagnetic signal without saturation from the magnetization versus applied field (M-H) curve of (Fig. 36) . The strong paramagnetic signal is due to the high surface-to-volume ratio and surface iron-ligand complexation. A high percentage of surface iron atoms interacted with the capping molecules through coordination bonds, forming a layer of iron-ligand complexes. The surface layer is mainly paramagnetic, the so-called magnetic ''dead layer'' on the nanoparticle surfaces, which is commonly observed in small magnetic nanoparticle systems [108] [109] [110] [111] [112] .
The as-synthesized nanowhiskers are only soluble in organic solvent and they must be transferred into aqueous solution for any biological or biomedical applications. The oleate-and oleylamine-coated iron oxide nanowhiskers were transferred into aqueous solution using tween-80 as capping molecules through a second layer encapsulation approach [255] . Specifically, polysorbate 80 (tween 80), an amphiphilic biocompatible polymer in water was mixed with nanowhisker organic solution under sonication. The hydrophobic region of tween-80 interacts with the hydrophobic tail of the ligand molecules on the nanowhisker surfaces, leaving the ethylene oxide polymers exposed for water solubility and biocompatibility.
The T 1 -weighted MR images of a Sprague-Dawley rat collected on a 3T clinical MRI scanner also showed strong enhancement for both subcutaneous and intraperitoneal injection. Figure 37a -c shows T 1 -weighted MR images of a Sprague-Dawley rat collected on a 3T clinical MRI scanner (Philips Achieva). The nanowhiskers were administrated intraperitoneally and subcutaneously. T 1 -weighted MR images of the animals were recorded pre-injection and 1-min post-injection. The abdominal region of the IP injected animal (Fig. 37b) shows brightening compared with the pre-injection image in Fig. 37a , suggesting the strong positive contrast enhancement of iron oxide nanowhiskers. The bleb from the subcutaneous injection (red circle) clearly shows T 1 enhancement due to the contrast agent (Fig. 37c) . Both of these studies indicated the feasibility to generate positive contrast enhancement in vivo using ultrathin iron oxide nanowhiskers under standard MRI settings. The successful development of iron oxide nanoparticle-based T 1 contrast agents will not only fulfill the need of patients with special conditions during an MRI scan, but also greatly benefit healthy patients who need MRI scans, potentially leading to the advancement of human health.
Pharmacokinetic pathways of iron oxide nanoparticles
Superparamagnetic iron oxide nanoparticles (SPIONs) are the only class of magnetic nanoparticle materials with a history of clinical use. First introduced in the early nineties, clinically approved SPIONs were used as MRI contrast agents providing negative (T 2 /T 2 *) contrast enhancement, but their use as such has declined since market-wide discontinuation of SPION agents. Currently, Feraheme Ò (ferumoxytol)-clinically approved for treating iron deficiency in anemia patients [256] -is the only nonstoichiometric magnetite SPION formulation actively produced and marketed. However, novel technologies such as MPI [33, 205, 257, 258] and emerging applications such as magnetic SLNB [259, 260] are reviving clinical interest in SPION agents. Unlike the MRI contrast predecessors, however, a new class of SPIONs with precisely tailored physicochemical properties are necessary. Further, the physicochemical and magnetic properties of SPIONs must be preserved in the physiological environment to ensure consistent performance after in vivo administration. Thus, SPION pharmacokinetics (PK) must be well characterized and controlled for translational application of these emerging technologies. In this section, we review the physicochemical properties of SPIONs that affect their principle pharmacokinetic properties-absorption, distribution, metabolism and excretion, typically referred together as ''ADME'' properties, and are defined as follows: Absorption-traditionally defined for orally administered drugs, absorption involves two important steps: (1) absorption of the inactive drug through physiological barriers (e.g., GI tract for oral administration), and (2) release or bioavailability of the active drug into systemic circulation. For intravenously administered SPIONs, absorption is bypassed and bioavailability is considered 100 % as the drug directly enters systemic circulation. A critical parameter of bioavailability is the blood half-life, which is the time it takes to reach 50 % of the initial concentration in blood.
Distribution is defined as the reversible accumulation of the circulating drug in various organs or tissues, and depends on factors such as vascular permeability, organ perfusion, plasma protein binding, and macrophage uptake. Drugs or SPIONs that avoid protein binding and macrophage uptake in organs may re-enter systemic circulation.
Metabolism involves the irreversible breakdown of the drug into smaller metabolites. SPIONs are typically metabolized in organs comprising the mononuclear phagocytic system (MPS).
Excretion is the removal of the drug and its metabolites. As will be discussed in a later section, the body's conservative iron cycle limits active excretion of SPIONs. Iron oxide is instead recycled and transformed into various storable or usable forms.
Influence of physiological barriers on SPION pharmacokinetics
The selection of an in vivo administration route plays a critical role in dictating SPION PK. Critically, the body's ''first line of defense'' or physiological barriers that govern PK for an intravenous (IV) injection are different from a subcutaneous or oral administration. Traditionally, IV injection has been the preferred administration route for SPIONs as it provides rapid bioavailability of the iron oxide cores in the active superparamagnetic state. Thus, we first review the physiological barriers that SPIONs encounter following IV injection, followed by other routes such as subcutaneous and oral administration.
The vasculature network constructed from endothelial cells is the primary route for material exchange between blood and tissues. The structure of blood vessels, especially finer capillaries that penetrate deep in organs, is variable and tailored to facilitate the specific functions of organs they supply. For instance, the blood-brain barrier (BBB) [261] is a highly selective vascular network in the brain that allows for exchange of only essential micronutrients, although occasionally larger molecules and nanoparticles can permeate through a receptor-mediated transcytosis pathway [262] . On the other hand, organs responsible for filtering and detoxifying blood consist of fenestrated capillaries to allow for extraction of macromolecules and nanoparticles. Figure 38 provides a general illustration of blood vessel morphology in some vital organs that partake in the clearance of drugs and nanoparticles.
The bioavailability of IV injected SPIONs depends on their ability to remain systemic and curtail irreversible removal from fenestrated capillaries in the kidneys, liver, spleen, and bone marrow. In kidneys, certain globular proteins (less than 20,000 Da) and water-soluble drug molecules [263] are filtered out from blood in the glomeruli capillary folds (Fig. 38a) . The filtrate enters the encapsulating Bowman capsule and eventually gets excreted with urine. However, unlike in the sinusoid capillaries of the liver and spleen, a basement membrane provides structural integrity to the glomeruli capillaries and limits fenestrae size from about 5 nm to no greater than 15 nm [264, 265] . Most SPIONs larger than 15 nm in hydrodynamic diameter avoid renal filtration and instead distribute in organs that host the mononuclear phagocyte system (MPS)-a system of phagocytic cells that reside in the sinusoid capillaries of the liver, spleen and lymph nodes, and as macrophage progenitors in the bone marrow [266] . Sinusoid capillaries are highly fenestrated vessels that lack a continuous basement membrane, allowing for greater vascular permeability and blood perfusion in the host organ, and thus increasing the probability for phagocytosis and removal by resident MPS cells. In the sinusoid capillaries of the liver (Fig. 38b) , fenestrae can range from 50 to 180 nm and allow for macromolecular exchange between the sinusoid lumen and hepatocytes through the plasma-rich perisinusoidal space (or Disse space) [267, 268] . The phagocytic MPS cells of the liver, also called Kupffer cells, reside in the sinusoid capillaries. Phagocytic removal of SPIONs and other nanoparticles occurs when plasma proteins called opsonins adsorb onto the particle surface and enable recognition by Kupffer cells and other phagocytic cells comprising the MPS; thus, avoiding or minimizing opsonin binding should be a critical requirement for designing longcirculating SPIONs.
In the spleen (Fig. 38c) , sinusoid capillaries are morphologically distinct from that of the liver [71] . Blood from terminal arterial openings flows into the red pulp-a region engorged with dead erythrocytes and platelets (thus the red appearance)-where it undergoes filtration by seeping through the 200-500 nm-wide interendothelial slits (IES) [265, 269] before re-entering systemic circulation. The deformability of healthy erythrocytes allows them to pass through the relatively smaller IES, while rigid structures such as dead erythrocytes or nanoparticles greater than 200 nm in diameter get trapped in the red pulp. Macrophages residing in the spleen eventually phagocytose material accumulated against the IES [269] . SPIONs can also passively accumulate in certain fast-growing tumors; tumor vasculature is highly permeable and suffers from poor lymphatic drainage, which results in a phenomenon called the enhanced permeability and retention (EPR) effect. Passive accumulation of SPIONs and other macromolecules using the EPR effect has been proposed as a ''silver bullet'' approach to targeting a wide spectrum of cancers; however, translation from well-controlled preclinical to realistic clinical models has been slow possibly due to heterogeneity in tumors and the surrounding vascular morphology [270] . SPION administration through routes other than IV injection are less common for their wide clinical use as imaging agents but prevalent for other budding applications. For instance, subcutaneous or peritumoral injection is more appropriate than IV injection for Sentinel Lymph Node detection and Biopsy (SLNB)-an emerging area of clinical application for magnetic SPIONs [260, [271] [272] [273] . In a typical magnetic SLNB procedure [259] , SPIONs are injected subcutaneously near the tumor, from where a portion of the injected material traverses through the draining lymphatic vessels and localizes in the sentinel lymph nodes. Lymph nodes consist a large number of phagocytic lymphocytes and macrophages that uptake SPIONs and cease further advancement. However, SPIONs with nonfouling coatings that minimize phagocytic uptake can continue draining to higher echelon nodes or even enter a nearby blood vessel, where they eventually disseminate through one of the systemic pathways discussed above. Finally, oral administration is less common but also a possible administration route for SPIONs. GastroMARK Ò (ferumoxsil, Mallinckordt Inc.) was an aqueous dispersion of silicone-coated SPIONs intended for oral administration and MR-imaging of the gastrointestinal (GI) tract. Since the intended use of GastroMARK was primarily diagnostic imaging of the bowels, the surface coating was designed to minimize absorption in the GI tract and excrete the material out with feces. The fraction of SPIONs that do get absorbed through the GI tract enter systemic circulation, but the SPION may break down during the absorption process and its bioavailability in the superparamagnetic state will be limited-a major reason why IV administration of SPIONs is preferred for delivery to organs outside the GI tract. On the other hand, it should be possible to design ''prodrug'' formulations that protect the active SPION composition during GI absorption.
Influence of surface properties on SPION pharmacokinetics
The preceding discussion presents a general summary of physiological barriers SPIONs encounter through various administration routes. In the following section, we consider the influence of surface physicochemical properties on the pharmacokinetic characteristics of SPIONs. Note that the scope of this discussion is limited to low aspect ratio particles, which are representative of nanoparticles typically synthesized and thus extensively studied and used in clinical applications. SPIONs intended for in vivo use typically consist of an external shell coating to help stabilize and protect the magnetic cores in physiological environments. While inorganic shells are common, organic coatings such as dextran-based carbohydrates and hydrophilic polymers like polyethylene glycol (PEG) are preferred because of their relative biocompatibility and functionalization versatility. The physicochemical makeup of coatings contributes significantly to the hydrodynamic diameter (d H ), net surface charge, and coating coverage-all being the critical design parameters that determine the in vivo fate of nanoparticles.
Size Hydrodynamic diameter (d h ) of a SPION, also called the Stokes diameter, is its diameter when dispersed in a solvent and includes the nanoparticle core, shell, and any associated solvent layer that diffuses as an extension of the coating. In view of the different physiological barriers discussed above, d h is an important parameter that affects SPION permeability through capillary fenestrae. Renal filtration is particularly dominant when d h is smaller than the 5-15 nm kidney fenestrae. Long-circulating SPIONs must preferably have d h greater than 15 nm to avoid rapid renal clearance. At the other extreme, SPIONs larger than the average spacing between interendothelial slits in the spleen (200-500 nm) will be retained and eventually get cleared by macrophages in the red pulp. Strictly going by the lower and upper size limits enforced by physiological barriers in the kidney and spleen, SPIONs with d h between 15 and 200 nm should have reasonable blood retention or blood half-life times. In practice, however, PK studies with dextran and PEG-coated SPIONs showed that circulation time (blood half-life) decreases with the increase in d h (assuming size within the 15-200-nm window) [70, 274, 275] . The latter finding is in line with cellular uptake studies that show greater phagocytic uptake in monocytes [276] and other cancer cell lines [277] when d h is increased, suggesting larger nanoparticles are more susceptible to opsonin binding, aggregation, and subsequent macrophage-mediated clearance in MPS organs like the liver and spleen [278] [279] [280] . Thus, reducing opsonin binding is critical to designing long-circulation SPIONs.
Charge In addition to size, surface charge is a critical surface property that dictates opsonin binding. Unlike size, shape, and curvature that only affect the number of bound proteins, surface charge plays a significant role in their identity; positively charged nanoparticles preferentially adsorb negatively charge proteins and vice versa [281] . A survey of the literature shows that nanoparticles with neutral or zwitterionic surfaces have lower opsonization rates than charged particles, and thus retained longer in circulation [279, [281] [282] [283] . Metz et al. [276] showed that a carboxydextran (negatively charged)-coated SPION formulation called SHU 555C (d h * 21 nm) showed greater uptake in monocytes than the comparable sized nonionicdextran-coated ferumoxtran-10 (d h * 20-50 nm). Further, the study suggested that surface charge induced a greater phagocytic effect than size as carboxydextran-coated ferucarbotran (d h = 62 nm) showed threefold uptake in monocytes than the significantly larger (d h = 150 nm) nonionic-dextran-coated ferumoxides. On the other hand, surface charge may be useful if efficient cell penetration is a desired application, which is the case in nonviral delivery of DNA or siRNA to cells using charged polymers [6, 284] . Positively charged polymer coatings such as poly(-ethyleneimine) (PEI) enhance cell penetration due to electrostatic attraction to the negatively charged phospholipid-lined cell membranes.
Coating density Hydrophobic surfaces, due to their insolubility in aqueous environments, often undergo rapid nonspecific protein adsorption and must be cloaked when designing long-circulating SPIONs. PEG is particularly attractive for coating hydrophobic SPION cores due to its exceptional nonfouling characteristics [285, 286] . Nevertheless, even partially hydrophobic regions, which may not affect solubility in aqueous media, can agglomerate SPIONs in biological media due to opsonin binding in a physiological environment. Thus, the density or surface coverage of coatings is another critical parameter in designing long-circulating SPIONs. For PEG-coated nanoparticles, low or high surface coverage results in either a 'mushroom' or 'brush' configuration, respectively [280] . In the mushroom state, PEG chains have greater mobility due to increased distance between neighboring polymers. The low coverage however, exposes significant portions of the underlying core, providing easy access for opsonin binding. At the other extreme, high surface coverage extends PEG chains further into the solvent, but, in addition reduces chain flexibility and mobility-critical properties of PEG responsible for its nonfouling characteristics [286] . Thus, optimal PEG conformation must facilitate both sufficient coverage and PEG chain mobility to prevent access to opsonins and enhance nanoparticle stability.
SPION metabolism and the iron cycle
The systemic bioavailability of SPIONs eventually decreases as their distribution in the MPS organs-liver, spleen, and lymph nodes-becomes irreversible due to opsonin binding and phagocytic uptake. This starts the metabolism process, which is the next step in the pharmacokinetic cycle of SPIONs. Since iron is an essential component of the body's hematopoietic cycle, it is incorporated in the physiological iron cycle and either utilized or conserved for future use [287, 288] . An illustration of the iron cycle is provided in Fig. 39 . SPIONs phagocytosed in MPS cells are digested in the acidic lysosomes and sequestered in ferritin and hemosiderin protein cages. About 1.5 grams of the body's total iron, primarily distributed in the liver parenchyma and other MPS cells, is stored in this manner [289] . The iron is stored in a nontoxic mineral form consisting a mixture of magnetite, hematite, and ferrihydrite phases [296] . In addition to storage, ferritin and hemosiderin also serve to supply iron for hemoglobin production during erythropoiesis (red blood cell production) in the bone marrow. Hemoglobin in erythrocytes uses up about 2 g of iron, which is about 2/3 of the total iron in the body. Myoglobin proteins in muscles account for another 10 %; together, hemoglobin and myoglobin represent the lion's share of iron utilized for physiological function. Finally, the amount of iron loss is about the same as the amount of iron absorbed from dietary intake-about 1-2 mg per day. In summary, the iron cycle is highly conserved and SPIONs metabolized in the liver and other MPS organs are eventually incorporated in either the storage or utilization pathways. Fig. 39 SPIONs administered in vivo distribute in the liver, spleen, and lymph nodes. MPS cells digest the nanoparticles and store the iron in ferritin and hemosiderin proteins. Since iron is highly conserved in the body, the SPIONs are eventually recycled and incorporated to some degree of storage and utilization in the physiological iron cycle. Figure adapted from Ref. [289] Perspectives and outlook It is clear from this comprehensive review of our work that research in magnetic nanoparticles, particularly phase-pure magnetite, with tailored sizes, narrow size distributions and optimized surface functionalities, has reached a sophisticated level of optimization. In fact, we are at the cusp of realizing major translational applications in biomedical imaging, diagnostics and therapy. Much of this progress is due to careful material engineering at the nanoscale, both of the nanoparticle core properties, to tailor their magnetic response, and its surface functionalization for molecular imaging (targeting), biocompatibility, and controlled circulation. Further progress will occur only if careful attention is paid to in vivo biological constraints, including addressing challenges of ensuring continued optimal magnetic response in the ''harsh'' in vivo environment, minimizing toxicity, achieving appropriate circulation times and controlling their biodistribution and clearance. In parallel, as we have described, the monodispersity of such nanoparticles lends them to large-area self-assembly with unique possibilities in creating lithographic structures at the *10-nm length scale and potentially impacting broadly on energy and information technologies. 
